- 86k views
Cardiac arrest and its management in emergency
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
About the Speaker
Dr.Vishant Sharma
Medical officer, Dept of Emergency, Civil Hospital District Shimla, Dept of Health and family welfare, Himachal Pradesh
Dr Vishant sharma completed his MBBS from rajiv gandhi university bangalore. Diploma in community mental health , nimhans bangalore . Dept of health and family welfare for himachal pradesh for 5 years. Masters in emergency medicine and trauma USA. Currently working in max super speciality hospital gurgaon Haryana.
Upcoming Case Discussions
Technology Integration with Healthcare
Technology integration in healthcare is transforming the way medical services are delivered, enhancing efficiency and patient outcomes. Innovations such as telemedicine, electronic health records (EHR), and wearable devices allow for real-time monitoring and improved accessibility. Artificial intelligence (AI) and machine learning aid in early diagnosis and personalized treatment plans. Robotic surgeries and advanced imaging techniques offer precision and reduced recovery times. By combining technology with healthcare, providers can streamline operations, improve patient engagement, and deliver cost-effective care solutions.
Pediatric Obesity: Treatment Management
Treatment management for pediatric obesity combines lifestyle changes, family support, and, in severe cases, medical interventions. Family-based strategies are key, encouraging healthy eating habits, regular physical activity, and reduced screen time. Behavioral therapy helps set achievable goals and address barriers, empowering children and families to make sustainable lifestyle adjustments. Dietitians often assist in designing individualized meal plans that focus on nutrient-rich foods and limit calorie-dense options. In cases of severe obesity with related health conditions, medications or surgery may be considered, particularly for adolescents. Continuous monitoring and support from healthcare providers are essential for long-term success and health improvement.
Clinician’s Approach to Sleep Apnea
A clinician's approach to sleep apnea begins with a thorough assessment of the patient's medical history, symptoms (such as snoring, choking, and daytime fatigue), and risk factors like obesity or hypertension. Diagnosis is typically confirmed through polysomnography or home sleep apnea testing, followed by treatment strategies such as continuous positive airway pressure (CPAP), lifestyle modifications, or surgical interventions depending on the severity and type of sleep apnea.
Case Based Approach to Arthritis
A case-based approach to arthritis involves analyzing individual patient cases to tailor diagnostic and therapeutic strategies based on specific symptoms, disease progression, and underlying causes. This method enhances clinical decision-making by providing personalized treatment plans and improving patient outcomes in conditions like osteoarthritis, rheumatoid arthritis, and psoriatic arthritis.
Addressing Nutrient Requirements in Toddlers and Preschool Children
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr.Vishant Sharma 's Talks on Assimilate
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.